Literature DB >> 17692677

Incidence of fungal infections in a solid organ recipients dedicated intensive care unit.

F Pugliese1, F Ruberto, A Cappannoli, S M Perrella, K Bruno, S Martelli, V Marcellino, A D'Alio, D Diso, M Rossi, S G Corradini, V Morabito, M Rolla, G Ferretti, F Venuta, P B Berloco, G F Coloni, P Pietropaoli.   

Abstract

UNLABELLED: Invasive fungal infections are a significant cause of morbidity and mortality for patients undergoing solid organ transplantation. Our aim was to evaluate the incidence of invasive fungal infections in solid organ recipients within a dedicated intensive care unit (ICU).
MATERIALS AND METHODS: From May 2002 to May 2005, 278 patients undergoing solid organ transplantation (105 liver, 142 kidney, 20 lung, 2 combined liver-kidney, 9 combined pancreas-kidney) were admitted to our posttransplant intensive care unit. We retrospectively analyzed data obtained from the ICU stay. Fungal infection was defined by positivity of normally sterile biological samples and by elevated positivity of normally non sterile biological samples. We did not consider superficial fungal infections and asymptomatic colonizations.
RESULTS: Forty-six patients (16.5%) developed a fungal infection; at least one mycotic agent was isolated from each patient. Candida albicans was the most common pathogen, isolated from 71 % of infected patients (33 of 46). Infected patients showed a mortality rate of 35%, while that for non infected recipients was 3.5%. Total length of ICU stay was the most significant risk factor among infected patients (30.26 days vs 5.04 days P < .0001). Mean time between transplantation and first positive samples was 6.17 days (SD 8.88).
CONCLUSION: Fungal infections in solid organ transplant patients are a major issue because of their associated morbidity and mortality. Candida albicans was the most common pathogen and total length of ICU stay was the most important risk factor.

Entities:  

Mesh:

Year:  2007        PMID: 17692677     DOI: 10.1016/j.transproceed.2007.05.060

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Airway anastomosis for lung transplantation.

Authors:  Marco Anile; Daniele Diso; Erino Angelo Rendina; Federico Venuta
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

Review 2.  Fungal infections in transplant and oncology patients.

Authors:  Anna K Person; Dimitrios P Kontoyiannis; Barbara D Alexander
Journal:  Infect Dis Clin North Am       Date:  2010-06       Impact factor: 5.982

3.  Pancreatic Candidiasis That Mimics a Malignant Pancreatic Cystic Tumor on Magnetic Resonance Imaging: A Case Report in an Immunocompetent Patient.

Authors:  Minjung Seong; Tae Wook Kang; Sang Yun Ha
Journal:  Korean J Radiol       Date:  2015-10-26       Impact factor: 3.500

4.  Epidemiology of invasive mold infections in lung transplant recipients.

Authors:  C T Doligalski; K Benedict; A A Cleveland; B Park; G Derado; P G Pappas; J W Baddley; D W Zaas; M T Harris; B D Alexander
Journal:  Am J Transplant       Date:  2014-04-11       Impact factor: 8.086

5.  Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study.

Authors:  M Winkler; J Pratschke; U Schulz; S Zheng; M Zhang; W Li; M Lu; D Sgarabotto; G Sganga; P Kaskel; S Chandwani; L Ma; J Petrovic; M Shivaprakash
Journal:  Transpl Infect Dis       Date:  2010-01-11       Impact factor: 2.228

6.  Invasive Fungal Disease in Pediatric Solid Organ Transplant Recipients.

Authors:  Shikha Saxena; Jerica Gee; Sarah Klieger; Adriana Kajon; Hans Petersen; Theoklis Zaoutis; Brian Fisher
Journal:  J Pediatric Infect Dis Soc       Date:  2018-08-17       Impact factor: 3.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.